Abdolkarim Sheikhi | Vaccine | Best Researcher Award

Posted on by sciencefather

Prof . Abdolkarim Sheikhi | Vaccine | Best Researcher Award

Assistant Professor , Queens University , Canada.

Abdolkarim Sheikhi is a renowned Iranian immunologist born in Dezful, Iran, on December 22, 1965. With a distinguished academic career, he is currently a Full Professor at Dezful University of Medical Sciences. He has held positions at various universities, including Zanjan University and Queen’s University. Sheikhi’s research mainly focuses on immunology, particularly cancer immunology and immune cell interactions. He has a deep commitment to teaching and has mentored numerous students. His professional contributions include several prestigious publications, with his work widely cited in international journals. 📚💡🧬

Profile 

Google scholar 

Education & Experience

Abdolkarim Sheikhi earned his B.Sc. in Biological Sciences from Shahid Chamran University (1989), an M.Sc. in Medical Immunology from Tarbiat Modarress University (1992), and a Ph.D. in Medical Immunology from Shiraz University of Medical Sciences (2002). His career includes various academic positions such as Lecturer and Professor at Zanjan, Dezful, and Queen’s Universities. He has gained experience as a visiting scientist in multiple countries, including Canada, Germany, and the Netherlands. Sheikhi is also known for establishing immunology and cell culture labs at universities and clinics. 🧑‍🎓🌍🔬

Professional Development 

Abdolkarim Sheikhi’s career is marked by continuous professional development. He has attended specialized courses at Queen’s University, including Radiation Safety, RT-PCR, and Animal Care. His postdoctoral work in various labs worldwide, including in Canada, Germany, and the Netherlands, has advanced his skills in molecular immunology, cancer research, and NK cell studies. Sheikhi has also contributed to the development of immunology labs and clinics focused on infertility treatment and autoimmune therapy. His role in various scientific committees and editorial boards has further honed his expertise and global impact in the field of immunology. 💼🧬💪

Research Focus 

Abdolkarim Sheikhi’s research primarily focuses on immunology, with particular interest in natural killer (NK) cells, cancer immunotherapy, and immune cell interactions. His studies explore the role of soluble HLA molecules in immune responses and their interaction with NK cells in cancerous environments. Sheikhi has made significant contributions to understanding immune modulation, such as the effects of probiotics on cytokine secretion and the development of bispecific antibodies for tumor targeting. His work also investigates the immunological mechanisms in autoimmune diseases and metabolic disorders, offering valuable insights into therapeutic interventions. 🧬💉🔬

Publications

  • “Kefir: a powerful probiotics with anticancer properties” (216 citations, 2017) 🧑‍🔬📖
  • “Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide” (174 citations, 2008) 🌱💡
  • “Study of Porphyromonas gingivalis in periodontal diseases: A systematic review and meta-analysis” (113 citations, 2017) 🦠📑
  • “Circulating levels of interleukin-35 in patients with multiple sclerosis” (113 citations, 2015) 🧠🦠
  • “Higher circulating levels of chemokine CXCL10 in patients with breast cancer” (92 citations, 2016) 💪🩺
  • “A review of trafficking and activation of uterine natural killer cells” (77 citations, 2005) 🌸🧬

Prof. Dr. Alejandra de-la-Torre|Immunology|Best Researcher Award

Posted on by sciencefather

Prof. Dr. Alejandra de-la-Torre|Immunology|Best Researcher Award

Prof. Dr. Alejandra de-la-Torre|Universidad del Rosario|Colombia

Alejandra de la Torre Cifuentes is a distinguished Colombian researcher in ophthalmology and immunology 🩺🧬. Fluent in Spanish, French, and English 🌍, she is known for her groundbreaking work on ocular diseases like uveitis, ocular toxoplasmosis, and dry eye syndrome 👁️. With dual doctorates in Translational Medicine and Biomedical Sciences from Universidad de Estrasburgo and Universidad del Quindío 🎓, she has a passion for integrating clinical practice and cutting-edge immunological research. Currently a Senior Researcher and Professor at Colegio Mayor Nuestra Señora del Rosario 📚, she has mentored students and published extensively on ophthalmic immunology.

Professional profile

Scopus

Suitability

Alejandra de la Torre Cifuentes stands out as an exemplary candidate for the Best Researcher Award due to her outstanding contributions to ophthalmology and immunology 🏆. With a robust academic background, including dual doctorates in Translational Medicine and Biomedical Sciences 🎓, she has demonstrated unparalleled dedication to advancing our understanding of ocular diseases such as uveitis, dry eye syndrome, and ocular toxoplasmosis 👁️. Her multidisciplinary research integrates clinical practice with immunological science, addressing complex eye conditions through innovative diagnostic and therapeutic solutions 🧬.

Education

  • 🎓 Doctorate: Translational Medicine (2009–2013) – Universidad de Estrasburgo.
  • 🎓 Doctorate: Biomedical Sciences (2009–2013) – Universidad del Quindío.
  • 👩‍⚕️ Specialization: Ocular Immunology and Uveitis – Harvard University.
  • 👩‍⚕️ Specialization: Ophthalmology – Pontificia Universidad Javeriana.
  • 🎓 Undergraduate: Medicine – Pontificia Universidad Javeriana (1981).

Profession

Alejandra de la Torre Cifuentes has made significant contributions to ophthalmic immunology through advanced research and clinical practice 🧬👁️. She has led innovative studies on infectious ocular diseases, dry eye syndrome, and allergic eye conditions 🌡️💉. Known for her interdisciplinary teaching 📖, she has designed postgraduate courses on uveitis and ocular immunology while mentoring the next generation of biomedical researchers 🎓. With experience at globally renowned institutions like Harvard University 🏛️ and Universidad de Estrasburgo, Alejandra is committed to advancing medical knowledge through immunological and translational approaches 🌍.

Experience

  • 🏢 Professor and Researcher – Colegio Mayor Nuestra Señora del Rosario (2012–Present).
  • 👁️ Ophthalmologist – Fundación Oftalmológica Nacional (2014–2019).
  • 🔬 Research Associate – Universidad de Estrasburgo (2009–2013).
  • 🏥 Ophthalmologist – Fundación Santa Fe de Bogotá (2002–2005).
  • 🏫 Instructor and Head of Ophthalmology Services – Pontificia Universidad Javeriana (1991–2005).

Research Focus

Alejandra focuses on integrating immunology and ophthalmology to address complex eye conditions 👀🧬. Her work spans uveitis, dry eye disease, and ocular toxoplasmosis, with emphasis on immunological mechanisms driving these disorders ⚗️. Through cellular biology and microbiology approaches 🔬, she has advanced diagnostic and therapeutic solutions for eye diseases 🌡️. Her translational research bridges clinical needs with scientific innovation to improve patient outcomes in ocular health 🏥. Passionate about education, she trains specialists in biomedical research and ophthalmic immunology 🌟📚, ensuring her work has lasting global and interdisciplinary impact 🌍.

Awards and Honors

  • 🏅 Outstanding Research Award – Colegio Mayor Nuestra Señora del Rosario.
  • 🥇 Distinguished Alumni Award – Pontificia Universidad Javeriana.
  • 🎖️ Honorary Medal for Translational Medicine – Universidad de Estrasburgo.
  • 🌟 Best Ophthalmology Paper of the Year – International Ocular Immunology Society.

Publications top notes

    • “Anterior chamber inflammation grading methods: A critical review”
      • Citations: 3 📝
    • “Prevalence and clinical characteristics of uveitic glaucoma: multicentric study in Bogotá, Colombia”
      • Citations: 3 📝
    • “Epidemiology, clinical features, and classification of 3,404 patients with uveitis: Colombian Uveitis Multicenter Study (COL-UVEA)”
      • Citations: 1 📝
    • “Natural Language Processing in medicine and ophthalmology: A review for the 21st-century clinician”
      • Citations: 1 📝
    • “Managing a patient with uveitis in the era of artificial intelligence: Current approaches, emerging trends, and future perspectives”